Correlation Analysis
Eli Lilly & Co. vs UL Solutions Inc.
LLY vs ULS
+0.397
Light positive
When one moves up, the other tends to follow.
Eli Lilly & Co.
↗LLY
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Market cap 828.2B · 50,000 employees
UL Solutions Inc.
↗ULS
UL Solutions is a global leader specializing in a broad range of product testing, inspection, and certification services. UL Solutions is the for-profit branch out of three organizations under the UL Enterprise. TIC operations make up nearly all of UL Solutions' total revenue and are composed of two segments: industrial and consumer. UL Solutions' remaining business includes software and advisory, which complements its core TIC offerings. The firm operates globally.
Market cap 16.9B · 14,851 employees
Time Series
Relative Performance
Who Moves First
ULS leads LLY by 2 days
ULS tends to move before LLY.
After testing 13 timing shifts, the strongest relationship was +0.397 (they moved in the same direction).
Do They Crash Together?
Correlation by Market Regime
How these series behave when markets are rising, falling, or diverging. A correlation that holds in drawdowns is very different from one that only works in rallies.
Both Rising
+0.439
17 periods · Return correlation when both series rose
Both Falling
+0.248
8 periods · Return correlation when both series fell
Diverging
-0.642
10 periods · Return correlation when series moved apart
R-Squared
15.7%
Share of variance in one series explained by the other.
Trend Agreement
55.1%
How often both series moved in the same direction period-to-period.
Overlap Quality
497
Robust shared window — 497 usable pairs.
Significance
p < 0.001
95% CI: [0.320, 0.468]
Scatter
XY Regression
Pipeline
Data quality details
Pipeline
Data quality details
Pipeline Summary
497 paired data points survived the daily window.
Raw input
1,254
497
Normalized
1,254
497
Prepared
1,254
497
Aligned
497
497
Invalid removed
0
A: 0 / B: 0
Duplicates removed
0
A: 0 / B: 0
Alignment drops
757
A: 757 / B: 0
Series A
Eli Lilly & Co.
LLY
Market cap 828.2B · 50,000 employees
Stock · 1,254 raw → 1,254 prepared
Series B
UL Solutions Inc.
ULS
Market cap 16.9B · 14,851 employees
Stock · 497 raw → 497 prepared
Sign agreement
100.0%
How often both values share the same sign.
Zero crossings
15
Estimated crossover points between normalized spreads.
Slope
0.0548
Linear regression slope.
Intercept
14.0471
Linear regression intercept.
Related Extremes
Highest and Lowest Correlated
Saved 7 hours ago · ID: stock-lly-vs-stock-uls-daily